Diagnostic and Clinical Applications of Arginine Vasopressin/Copeptin Levels

Diagnostic Applications

In adults, baseline plasma copeptin levels above 21.4 pmol/L are diagnostic for nephrogenic diabetes insipidus (NDI), distinguishing it from other polyuric disorders, according to the guidelines from the European Society of Endocrinology 1
Adults with plasma copeptin <21.4 pmol/L should undergo further testing for AVP deficiency (central diabetes insipidus) and primary polydipsia using infusion tests with hypertonic saline or arginine, as recommended by the American Society of Nephrology 1
Genetic testing for AQP2, AVPR2, and AVP genes is recommended as the first-line diagnostic approach for suspected congenital NDI, with copeptin measurement serving as an alternative when genetic testing is unavailable or inconclusive, according to the International Society of Nephrology 1, 2
Copeptin measurement helps differentiate between various causes of polyuria and hyponatremia, including nephrogenic diabetes insipidus (elevated copeptin), central diabetes insipidus (low copeptin), and primary polydipsia (normal or low copeptin), as stated by the European Renal Association 1, 2
The differential diagnosis also includes poorly controlled diabetes mellitus, Bartter syndrome, distal renal tubular acidosis, and nephronophthisis, according to the National Kidney Foundation 2, 1

Copeptin levels can guide treatment decisions for vasopressin receptor antagonists (vaptans) in hypervolemic hyponatremia, as recommended by the American Association for the Study of Liver Diseases 3, 4
In patients with liver cirrhosis, caution is needed when using vaptans as drug metabolism may be approximately 60% slower in uncompensated cirrhosis, according to the European Association for the Study of the Liver 3, 5
Monitoring copeptin levels is important in patients undergoing pituitary surgery to detect changes in water metabolism and AVP regulation, which are common complications, as stated by the Endocrine Society 6

Normal electrolytes, particularly normal serum sodium, argue strongly against diabetes insipidus, as untreated DI typically presents with hypernatremia or a tendency toward it, according to the American Society of Nephrology 7
Normal kidney function excludes acquired nephrogenic diabetes insipidus from chronic kidney disease or electrolyte disturbances, as stated by the National Kidney Foundation 7
Patients with inappropriately dilute urine (osmolality typically <200 mOsm/kg H₂O) despite elevated copeptin are diagnostic for nephrogenic DI, as recommended by the European Renal Association 7

Copeptin levels can be used to diagnose nephrogenic diabetes insipidus, with a baseline copeptin level above a certain threshold being diagnostic, although the exact threshold is not specified in the provided text, the American College of Clinical Endocrinologists may provide further guidance 7